Clinical Trials Directory

Trials / Unknown

UnknownNCT05536674

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

Design, Test and Evaluate Behavioural Insights Interventions to Strengthen Demand for Immunisation in Georgia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
55,176 (estimated)
Sponsor
The Behavioural Insights Team · Academic / Other
Sex
Female
Age
10 Years – 12 Years
Healthy volunteers
Accepted

Summary

It is possible that achieving adequate HPV vaccination coverage will allow cervical cancer to be virtually eliminated. This is a priority for Georgia, where the burden of mortality and morbidity from cervical cancer is high and the yearly prevalence of cervical cancer is 14.5 per 100,000 population. The objective of the intervention evaluated is to increase the uptake of the 1st dose of the HPV vaccination in Georgia. The intervention aims to achieve this by providing a SMS reminder informed by behavioural insights (BI) to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination, share information about the vaccine, and encourage them to book an appointment to receive the vaccination. Four different SMS messages will be compared to no SMS message. The evaluation will be a 5-arm randomised controlled trial (RCT) which aims to answer the research question: Does each of the designed BI-informed SMS reminders increase the uptake of the first dose of the HPV vaccination among eligible girls in Georgia, compared to no reminder? Our hypothesis is that SMS reminders will increase the uptake of HPV vaccination.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS reminder for the HPV vaccinationA BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.

Timeline

Start date
2022-09-13
Primary completion
2022-11-12
Completion
2022-11-12
First posted
2022-09-13
Last updated
2022-09-13

Source: ClinicalTrials.gov record NCT05536674. Inclusion in this directory is not an endorsement.